by University of Minnesota Medical School Credit: Pixabay/CC0 Public Domain Published in PLOS ONE, a study led by the University of Minnesota Medical School studied adults with type 2 diabetes who were taking metformin, a commonly prescribed diabetes medication. Researchers found an association with less severe cases of COVID-19 for those prescribed metformin. These findings were...
Tag: <span>COVID-19 cases</span>
Stimulating the auricular vagus nerve has anti-inflammatory effects in severe Covid-19 cases
VIENNA UNIVERSITY OF TECHNOLOGY IMAGE: FROM LEFT: EUGENIJUS KANIUSAS, BABAK DABIRI UND ANDREAS DICKINGER CREDIT: TU WIEN A system out of balance When a virus – such as SARS-CoV-2 – triggers an inflammatory response in the body, this information is transmitted to the brain via the sensory nervous system. The Vagus nerve, which extends from...
MAIT cell activation may play a role in fatal outcomes among severe COVID-19 cases
by Public Library of Science Project design and overall conclusions of the St George’s, University of London and University of Oxford collaboration on immune parameters of ICU COVID-19 and severe influenza. Credit: Nicholas Provine, Jonathan Youngs, and Paul Klenerman, CC-BY 4.0, creativecommons.org/licenses/by/4.0/) The mortality rate of COVID-19 patients requiring mechanical ventilation is 30-40%, however, the immunological...
Wildfire smoke may have contributed to thousands of extra COVID-19 cases and deaths in the western US in 2020
by Harvard School of Public Health The Apple Fire burns into the night north of Beaumont on Friday, July 31, 2020. Credit: https://twitter.com/BrodyHessin/status/1289446228082663424 Brody Hessin/Wikimedia Commons CC/4.0 Thousands of COVID-19 cases and deaths in California, Oregon, and Washington between March and December 2020 may be attributable to increases in fine particulate air pollution (PM2.5) from wildfire smoke, according...
Trial shows that the antibiotic azithromycin does not prevent mild COVID-19 cases progressing to hospitalization or death
EUROPEAN SOCIETY OF CLINICAL MICROBIOLOGY AND INFECTIOUS DISEASES A new study (the ATOMIC2 trial), presented at this year’s European Congress of Clinical Microbiology & Infectious Diseases (ECCMID) and published simultaneously in The Lancet Respiratory Medicine, shows the antimicrobial drug azithromycin – already approved for use in multiple infections – does not prevent mild COVID-19 cases progressing...
Rogue antibodies wreak havoc in severe COVID-19 cases
YALE UNIVERSITY The development of antibodies to the COVID-19 virus has been the great long-term hope of ending the pandemic. However, immune system turncoats are also major culprits in severe cases of COVID-19, Yale scientists report in the journal Nature. These autoantibodies target and react with a person’s tissues or organs similar to ones that cause...